---
document_datetime: 2023-09-21 20:45:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/abiraterone-krka-epar-all-authorised-presentations_en.pdf
document_name: abiraterone-krka-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0843986
conversion_datetime: 2025-12-21 11:41:39.186182
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                     | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------------------------|-------------|
| EU/1/21/1553/001 | Abiraterone Krka  | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PE/PVDC//Pap/Alu)          | 56 tablets  |
| EU/1/21/1553/002 | Abiraterone Krka  | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PE/PVDC//Pap/Alu)          | 60 tablets  |
| EU/1/21/1553/003 | Abiraterone Krka  | 500 mg     | Film-coated tablet    | Oral use                  | Calendar blister (PVC/PE/PVDC//Pap/Alu) | 56 tablets  |